$ATOM
Atomera Inc Stock $atom

$atom Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000168316824001031 Filed on February 15, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$18.00K	$550.0K	$550.0K
YoY Change		10900.0%	43.98%
Cost Of Revenue	$33.00K	$28.00K	$28.00K
YoY Change			-65.43%
Gross Profit	-$15.00K	$522.0K	$522.0K
YoY Change		10340.0%	73.42%
Gross Profit Margin	-83.33%	94.91%	94.91%
Selling, General & Admin	$2.161M	$2.327M	$8.674M
YoY Change	1.41%	23.25%	11.36%
% of Gross Profit		445.79%	1661.69%
Research & Development	$2.858M	$2.992M	$12.53M
YoY Change	-5.86%	18.59%	24.78%
% of Gross Profit		573.18%	2399.43%
Depreciation & Amortization	$298.0K	$293.0K	$77.00K
YoY Change	1390.0%	-5.48%	0.0%
% of Gross Profit		56.13%	14.75%
Operating Expenses	$5.019M	$5.319M	$21.20M
YoY Change	-2.86%	20.58%	18.92%
Operating Profit	-$5.034M	-$4.797M	-$20.68M
YoY Change	-2.57%	8.87%	17.98%
Interest Expense	$166.0K	$152.0K	$194.0K
YoY Change	213.21%	13.43%	-23.92%
% of Operating Profit
Other Income/Expense, Net	$46.00K	$65.00K	$887.0K
YoY Change	-68.92%		943.53%
Pretax Income	-$4.822M	-$4.580M	-$19.79M
YoY Change	-3.93%	7.21%	13.47%
Income Tax
% Of Pretax Income
Net Earnings	-$4.822M	-$4.580M	-$19.79M
YoY Change	-3.93%	7.21%	13.47%
Net Earnings / Revenue	-26788.89%	-832.73%	-3598.18%
Basic Earnings Per Share	-$0.19		-$0.80
Diluted Earnings Per Share	-$0.19	-$0.18	-$0.80
COMMON SHARES
Basic Shares Outstanding	26.62M shares	25.80M shares	24.76M shares
Diluted Shares Outstanding	26.04M shares		24.76M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.26M	$19.53M	$19.53M
YoY Change	12.97%	-7.8%	-7.8%
Cash & Equivalents	$14.81M	$12.59M	$12.59M
Short-Term Investments	$4.458M	$6.940M	$6.940M
Other Short-Term Assets	$328.0K	$244.0K	$244.0K
YoY Change	8.25%	-41.63%	-41.63%
Inventory
Prepaid Expenses
Receivables	$0.00	$550.0K	$550.0K
Other Receivables	$73.00K	$79.00K	$79.00K
Total Short-Term Assets	$19.67M	$20.40M	$20.40M
YoY Change	13.31%	-5.55%	-5.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.164M	$100.0K	$3.520M
YoY Change	1967.97%	-36.71%	-29.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$105.0K	$105.0K	$105.0K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$3.269M	$3.625M	$3.625M
YoY Change	-31.61%	-29.3%	-29.3%
TOTAL ASSETS
Total Short-Term Assets	$19.67M	$20.40M	$20.40M
Total Long-Term Assets	$3.269M	$3.625M	$3.625M
Total Assets	$22.93M	$24.03M	$24.03M
YoY Change	3.61%	-10.1%	-10.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$601.0K	$618.0K	$618.0K
YoY Change	42.08%	55.67%	55.67%
Accrued Expenses	$927.0K	$222.0K	$1.868M
YoY Change	283.06%	28.32%	34.87%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.357M	$1.328M	$1.328M
YoY Change	9.44%	17.94%	17.94%
Total Short-Term Liabilities	$2.902M	$3.814M	$3.814M
YoY Change	18.74%	31.16%	31.16%
LONG-TERM LIABILITIES
Long-Term Debt	$1.431M	$1.750M	$1.750M
YoY Change	-46.66%	-41.39%	-41.39%
Other Long-Term Liabilities	$194.0K	$295.0K	$295.0K
YoY Change	-59.16%	-43.38%	-43.38%
Total Long-Term Liabilities	$1.625M	$2.045M	$2.045M
YoY Change	-48.54%	-41.69%	-41.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.902M	$3.814M	$3.814M
Total Long-Term Liabilities	$1.625M	$2.045M	$2.045M
Total Liabilities	$4.527M	$5.859M	$5.859M
YoY Change	-19.19%	-8.67%	-8.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$207.9M	-$203.1M
YoY Change	10.4%	10.8%
Common Stock	$226.3M	$221.3M
YoY Change	10.48%	8.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.41M	$18.17M	$18.17M
YoY Change
Total Liabilities & Shareholders Equity	$22.93M	$24.03M	$24.03M
YoY Change	3.61%	-10.1%	-10.1%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$4.822M	-$4.580M	-$19.79M
YoY Change	-3.93%	7.21%	13.47%
Depreciation, Depletion And Amortization	$298.0K	$293.0K	$77.00K
YoY Change	1390.0%	-5.48%	0.0%
Cash From Operating Activities	-$4.149M	-$2.907M	-$14.56M
YoY Change	-2.01%	-0.38%	16.47%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$1.000K	$31.00K
YoY Change	-100.0%	-92.31%	-20.51%
Acquisitions
YoY Change
Other Investing Activities	$2.521M	$880.0K	-$6.720M
YoY Change	-151.01%
Cash From Investing Activities	$2.521M	$879.0K	-$6.751M
YoY Change	-150.86%	-6861.54%	17210.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.843M	1.985M	$12.72M
YoY Change	2974.4%	139.73%	153.14%
NET CHANGE
Cash From Operating Activities	-4.149M	-2.907M	-$14.56M
Cash From Investing Activities	2.521M	879.0K	-$6.751M
Cash From Financing Activities	3.843M	1.985M	$12.72M
Net Change In Cash	2.215M	-43.00K	-$8.593M
YoY Change	-124.43%	-97.96%	14.34%
FREE CASH FLOW
Cash From Operating Activities	-$4.149M	-$2.907M	-$14.56M
Capital Expenditures	$0.00	$1.000K	$31.00K
Free Cash Flow	-$4.149M	-$2.908M	-$14.59M
YoY Change	-2.35%	-0.78%	16.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001420520
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-37850
CY2023	dei	Entity Registrant Name EntityRegistrantName	ATOMERA INCORPORATED
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-0509586
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	750 University Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 280
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Gatos
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95032
CY2023	dei	City Area Code CityAreaCode	(408)
CY2023	dei	Local Phone Number LocalPhoneNumber	442-5248
CY2023	dei	Security12b Title Security12bTitle	Common stock: Par value $0.001
CY2023	dei	Trading Symbol TradingSymbol	ATOM
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	215221176	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26619981	shares
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum llp
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, CA
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12591000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21184000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	6940000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2023Q4	ATOM	Unbilled Contracts Receivable Current UnbilledContractsReceivableCurrent	550000	usd
CY2022Q4	ATOM	Unbilled Contracts Receivable Current UnbilledContractsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	79000	usd
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	0	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	244000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	418000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	20404000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	21602000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	100000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	158000	usd
CY2023Q4	ATOM	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
CY2022Q4	ATOM	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	517000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	700000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2903000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4164000	usd
CY2023Q4	us-gaap	Assets Assets	24029000	usd
CY2022Q4	us-gaap	Assets Assets	26729000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	618000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	397000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	222000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	173000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1382000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	967000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	264000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	245000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1328000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1126000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3814000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2908000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	295000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	521000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1750000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2986000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5859000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6415000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	47500000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	47500000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26107000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26107000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23973000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23973000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	26000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	221229000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	203585000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-203085000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-183295000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18170000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20314000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24029000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26729000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	550000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	382000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	28000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	81000	usd
CY2023	us-gaap	Gross Profit GrossProfit	522000	usd
CY2022	us-gaap	Gross Profit GrossProfit	301000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12525000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10038000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7075000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6441000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1599000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1348000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	21199000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	17827000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-20677000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-17526000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	723000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	340000	usd
CY2023	ATOM	Accretion Income AccretionIncome	283000	usd
CY2022	ATOM	Accretion Income AccretionIncome	0	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	75000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023	us-gaap	Interest Expense InterestExpense	194000	usd
CY2022	us-gaap	Interest Expense InterestExpense	255000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	887000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	85000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19790000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17441000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.80
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.80
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24755000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23157000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24755000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23157000	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	28381000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3367000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	244000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5763000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17441000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19790000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17441000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	77000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20314000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4013000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	128000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13505000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19790000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18170000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	77000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	216000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	200000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1146000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1229000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	4013000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3367000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-254000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
CY2023	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	3000	usd
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-0	usd
CY2023	ATOM	Increase Decrease In Unbilled Contracts Receivable IncreaseDecreaseInUnbilledContractsReceivable	550000	usd
CY2022	ATOM	Increase Decrease In Unbilled Contracts Receivable IncreaseDecreaseInUnbilledContractsReceivable	-0	usd
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	31000	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-0	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-174000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	108000	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	221000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	59000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	49000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-30000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	415000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	366000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-240000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-218000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14557000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12499000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	15000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2023	ATOM	Purchase Of Availableforsale Securities PurchaseOfAvailableforsaleSecurities	19539000	usd
CY2022	ATOM	Purchase Of Availableforsale Securities PurchaseOfAvailableforsaleSecurities	-0	usd
CY2023	ATOM	Maturity Of Availableforsale Securities MaturityOfAvailableforsaleSecurities	12804000	usd
CY2022	ATOM	Maturity Of Availableforsale Securities MaturityOfAvailableforsaleSecurities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6751000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39000	usd
CY2023	ATOM	Proceeds From At The Market Sale Of Stock ProceedsFromAtTheMarketSaleOfStock	13505000	usd
CY2022	ATOM	Proceeds From At The Market Sale Of Stock ProceedsFromAtTheMarketSaleOfStock	5763000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	128000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	244000	usd
CY2023	ATOM	Payments Of Principal For Financing Lease PaymentsOfPrincipalForFinancingLease	918000	usd
CY2022	ATOM	Payments Of Principal For Financing Lease PaymentsOfPrincipalForFinancingLease	984000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12715000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5023000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8593000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7515000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21184000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28699000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12591000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21184000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	194000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	255000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_806_eus-gaap--NatureOfOperations_zM1QD6lb1Fp9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 29px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_821_zr1mXcUwt1V">NATURE OF OPERATIONS</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera Incorporated (“Atomera” or the “Company”) was incorporated in the state of Delaware in March 2007 under the name MEARS Technologies, Inc. and is engaged in the development, commercialization and licensing of proprietary processes and technologies for the semiconductor industry. On January 12, 2016, the Company changed its name to Atomera Incorporated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera is an early-stage company, having only recently begun limited revenue-generating activities, and is devoting substantially all its efforts toward technology research and development and to commercially licensing its technology to designers and manufacturers of integrated circuits. The Company operates as one business segment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	19500000	usd
CY2023Q4	ATOM	Working Capital WorkingCapital	16600000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_z3tjUn1DfOwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span id="xdx_86C_zbVq9ONwxroi">Concentration of Credit Risk and Major Customers</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash, cash equivalents, short-term investments and accounts receivable. One customer represented <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFhB35KZGN5k" title="Concentration of credit risk, percentage">100</span>% of revenue during the year ended December 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At times, the amounts on deposit at the financial institution exceed the federally insured limits. Management believes that the financial institution which holds the Company’s cash is financially sound and, accordingly, that minimal credit risk exists. As of December 31, 2023 and 2022, the Company’s cash balances were in excess of insured limits maintained at the financial institution.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zch8soJ5VTU1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_869_zmbVYBmTLTT2">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates are used when accounting for the fair value of stock-based compensation, borrowing rates used for lease accounting and valuation allowance against deferred tax assets. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	550000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	382000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	550000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	382000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3788000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3349000	shares
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	462000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	472000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	362000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	314000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	100000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	158000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation	77000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation	77000	usd
CY2023	us-gaap	Lessee Operating Lease Option To Terminate LesseeOperatingLeaseOptionToTerminate	The Company terminated its office lease in Cambridge, Massachusetts as of March 31, 2023. The cost of the lease was $2,942 per month.
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1146000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1229000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	194000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	255000	usd
CY2023	us-gaap	Lease Cost LeaseCost	1340000	usd
CY2022	us-gaap	Lease Cost LeaseCost	1484000	usd
CY2023	ATOM	Fixed Lease Costs FixedLeaseCosts	257000	usd
CY2022	ATOM	Fixed Lease Costs FixedLeaseCosts	248000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	2000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	0	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1045000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	35000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1304000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	283000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	272000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	265000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1112000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1239000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	33000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023	ATOM	Remeasurement Of Rightofuse Asset And Liability In Financing Lease RemeasurementOfRightofuseAssetAndLiabilityInFinancingLease	-115000	usd
CY2022	ATOM	Remeasurement Of Rightofuse Asset And Liability In Financing Lease RemeasurementOfRightofuseAssetAndLiabilityInFinancingLease	-458000	usd
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0525	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0548	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3400000	shares
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	4013000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3367000	usd
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	82000	usd
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	78000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19790000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17441000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4400000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4500000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27077000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	25309000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2559000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2197000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	603000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	798000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1327000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1052000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	303000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	212000	usd
CY2023Q4	ATOM	Deferred Tax Assets Tax Deferred Lease Liability DeferredTaxAssetsTaxDeferredLeaseLiability	802000	usd
CY2022Q4	ATOM	Deferred Tax Assets Tax Deferred Lease Liability DeferredTaxAssetsTaxDeferredLeaseLiability	1079000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3822000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1797000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	36493000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	32444000	usd
CY2023Q4	ATOM	Deferred Tax Liability Tax Right Of Use Asset DeferredTaxLiabilityTaxRightOfUseAsset	755000	usd
CY2022Q4	ATOM	Deferred Tax Liability Tax Right Of Use Asset DeferredTaxLiabilityTaxRightOfUseAsset	1076000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	755000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1076000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35738000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	31368000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0129	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0351	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2208	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2595	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.0002	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0066	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0070	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0	pure
CY2023	ATOM	Effective Income Tax Rate Reconciliation Section382 Limitation EffectiveIncomeTaxRateReconciliationSection382Limitation	0	pure
CY2022	ATOM	Effective Income Tax Rate Reconciliation Section382 Limitation EffectiveIncomeTaxRateReconciliationSection382Limitation	0	pure
CY2023	ATOM	Effective Income Tax Rate Reconciliation Section162 M Limitation EffectiveIncomeTaxRateReconciliationSection162MLimitation	-0.0011	pure
CY2022	ATOM	Effective Income Tax Rate Reconciliation Section162 M Limitation EffectiveIncomeTaxRateReconciliationSection162MLimitation	-0.0047	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0074	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0120	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1046000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	896000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	10000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	163000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	151000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1219000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1046000	usd
CY2022Q4	ATOM	Deferred Tax Assets Valuation Allowances DeferredTaxAssetsValuationAllowances	31368000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4536000	usd
CY2023	ATOM	Valuation Allowance Deferred Tax Asset Change In Amount Deduction ValuationAllowanceDeferredTaxAssetChangeInAmountDeduction	166000	usd
CY2023Q4	ATOM	Deferred Tax Assets Valuation Allowances DeferredTaxAssetsValuationAllowances	35738000	usd
CY2021Q4	ATOM	Deferred Tax Assets Valuation Allowances DeferredTaxAssetsValuationAllowances	26842000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4636000	usd
CY2022	ATOM	Valuation Allowance Deferred Tax Asset Change In Amount Deduction ValuationAllowanceDeferredTaxAssetChangeInAmountDeduction	110000	usd
CY2022Q4	ATOM	Deferred Tax Assets Valuation Allowances DeferredTaxAssetsValuationAllowances	31368000	usd

Files In Submission

Name	View Source	Status
0001683168-24-001031-index-headers.html	Edgar Link	pending
0001683168-24-001031-index.html	Edgar Link	pending
0001683168-24-001031.txt	Edgar Link	pending
0001683168-24-001031-xbrl.zip	Edgar Link	pending
atom-20231231.xsd	Edgar Link	pending
atomera_ex2301.htm	Edgar Link	pending
atomera_ex3101.htm	Edgar Link	pending
atomera_ex3102.htm	Edgar Link	pending
atomera_ex3201.htm	Edgar Link	pending
atomera_ex9701.htm	Edgar Link	pending
atomera_i10k-123123.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
atom-20231231_cal.xml	Edgar Link	unprocessable
atom-20231231_def.xml	Edgar Link	unprocessable
atom-20231231_lab.xml	Edgar Link	unprocessable
atom-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
atomera_i10k-123123_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ATOM
Atomera Inc Stock $atom

2024 Q1 Form 10-K Financial Statement

#000168316824001031 Filed on February 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOM Atomera Inc Stock $atom

2024 Q1 Form 10-K Financial Statement

#000168316824001031 Filed on February 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOM
Atomera Inc Stock $atom